BridgeMD
New treatment option for Benign Paroxysmal Positional Vertigo
Official title Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV
ClinicalTrials.gov ID: NCT06001047
What this study is testing
What is Group B?
Group B is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for benign paroxysmal positional vertigo.
Also referred to as betahistine group.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder, and currently, manual repositioning techniques are often used for treatment. However, up to 30%-50% of patients may experience residual symptoms such as non-rotational dizziness, heaviness, instability, and emotional disturbances even after successful repositioning, which significantly impacts their daily functioning and quality of life.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- According to the diagnostic criteria and therapeutic how well it works evaluation for benign paroxysmal positional vertigo (BPPV) formulated by the...
- After the maneuver, the patient's clinical symptoms were relieved, with no sense of rotation or dizziness, but residual symptoms such as discomfort...
- There were no obvious communication barriers or visual impairments.
- The patient and their family members agreed to the treatment plan.
You likely can't join if
- Patients with other ear diseases, history of head trauma or surgery;
- Patients who are weak and unable to tolerate, pregnant women;
- Patients who have undergone vestibular rehabilitation training before this treatment; ④ Patients with joint diseases that affect balance and walking...
The study team makes the final eligibility decision.
Where it's taking place
- Xi'an, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Xi'an, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.